- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Four imaging companies join in DR venture
Analogic will market and distribute versions of Fischer Imaging’s chest and general-purpose digital radiography systems under a multimillion-dollar agreement that grew out of last year’s RSNA convention. At that meeting, Kodak unveiled a deal
Analogic will market and distribute versions of Fischer Imagings chest and general-purpose digital radiography systems under a multimillion-dollar agreement that grew out of last years RSNA convention. At that meeting, Kodak unveiled a deal with Analogic and Direct Radiography for the two companies to collaborate on providing Kodak with DR systems.
Fischer made its debut with DR at that meeting and since then has installed several DR units throughout Europe and North America. Analogic signed a deal with Fischer Imaging to supply x-ray and hardware components that Analogic will integrate into Fischers systems before delivering them to Kodak.
Kodak will deliver the completed systems to healthcare providers, said Lou Rivelli, Fischers president and chief operating officer. The agreement is for a year, but it has the potential to continue longer, he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
